Summary
Vertebrate limb regeneration occurs in anamniotes such as newts, salamanders, and zebrafish [1] [2] [3] [4] . After appendage amputation, the resection site is covered by a wound epidermis capping the underlying mature tissues of the stump from which the blastema emerges. The blastema is a mass of progenitor cells that constitute an apical growth zone. During outgrowth formation, the proximal blastemal cells progressively leave the zone and undergo the differentiation that results in the replacement of the amputated structures. Little is known about the mechanisms triggering regenerative events after injury. The zebrafish caudal fin provides a valuable model to study the mechanisms of regeneration [3, 5, 6] . Zebrafish blastemal cells express specific genes, such as the homeobox-containing transcription factors msxB and msxC [7] , and secreted signal FGF20a [8] . In this study, we set out to identify signals that are transcriptionally upregulated after fin amputation and before blastema formation. Accordingly, a gene encoding a TGFb-related ligand, activin-bA (actbA), was found to be strongly induced within 6 hr after fin amputation at the wound margin, and later in the blastema. Inhibition of Activin signaling through two specific chemical inhibitors, SB431542 and SB505124, lead to the early and complete block of regeneration. The morpholino knockdown of actbA and its receptor alk4 impaired the progression of regeneration. Closer examination of the phenotype revealed that Activin signaling is necessary for cell migration during wound healing and blastemal proliferation. These findings reveal a role of Activin-bA signaling in the tissue repair after injury and subsequent outgrowth formation during epigenetic regeneration of the vertebrate appendage.
Results and Discussion
actbA Is Transcriptionally Upregulated during Fin Regeneration To identify early signals triggering regeneration, we performed Affymetrix microarray analyses comparing control fins collected immediately after amputation with regenerating fins at 6 hr postamputation (6 hpa) and at 28. 5 C. This time point falls into the phase during wound healing and before blastema formation. The transcriptome analysis lead to the identification of activin-bA in regenerating fins (inhibin-bA, actbA; Table S1 in the Supplemental Data available online). Act-bA is a secreted ligand that signals through a serine-threonine kinase complex consisting of type I receptor ActBIB (Alk4) and type II receptor ActRIIA or ActRIIB [9] . In order to examine the requirement of actbA, we intended to suppress the activity of its Alk4 receptor. Quantitative reverse transcription-polymerase chain reaction (RT-PCR) and in situ hybridization verified that the alk4 receptor is expressed in regenerating fins (Figures S1A and S1C). Given that the Alk4 receptor mediates the signaling of several structurally related ligands, we determined the expression of activin-bA, activin-bB, TGFb1, TGFb2, TGFb3, GDF8, GDF11, and the three nodal-related genes squint, cyclops, and southpaw [10] . Among ligands that are expressed in fins, activin-bA was the only gene transcriptionally upregulated during fin regeneration (Figures S1A and S1B). In comparison with 0 hpa fin samples, a nearly 5-fold increase of actbA transcript levels was detected as early as 1 hpa ( Figure 1B) . The highest upregulation of 18-fold was identified at 6 hpa, and it slightly declined at 24 hpa ( Figure 1B) .
The fin is composed of rays that are supported by dermal bones called lepidotrichia or hemirays [3, 5] . Rays are connected to each other through soft tissue interrays that lack skeletal elements. To visualize the expression of actbA in fins, we performed in situ hybridization. The first signal was detected at 6 to 12 hpa in mesenchymal cells at the wound margin of the interrays ( Figures  1A and 1C) . At 24 hpa, actbA transcription was also induced at the epidermal-mesenchymal boundary in the ray region where the blastema forms ( Figure 1E ). During regenerative outgrowth phase at 72 hpa, the expression of actbA was maintained in the blastema and declined in the initial interray domains ( Figure 1G ). We hypothesized that the early actbA expression in the interray pockets comprised a mesenchymal zone that is distinct from the blastema. To test this idea, we analyzed actbA expression in the amputated fins bearing the devoid of blastema (dob) mutation, a temperature-sensitive allele of the FGF20a gene [8] . In dob mutant fins, at 24 and 72 hpa at the restrictive temperature of 33 C, actbA expression was not detected in the ray mesenchyme, consistent with the notion that FGF20a is required for blastema formation ( Figures 1F and 1H) . However, the interray domains of actbA expression were normally established at 6 hpa and maintained at later stages at 24 and 72 hpa ( Figures 1D, 1F, and 1H ). This demonstrates that the early actbA expression domain is independent of blastema formation.
Inhibition of Activin-bA Signaling Blocks Regeneration
To test whether actbA is required during regeneration, we applied a pharmacological strategy to block Alk4-dependent signaling. We used two synthetic small molecules, 10 mM SB431542 and 2 mM SB505124, that specifically block Alk4/5/7 receptor, not affecting other Alk family members, as well as other signal transduction pathways [11, 12] . SB431542 (Alk4-i) was shown to inhibit the Activin type I receptor in zebrafish embryos [13, 14] . SB505124 caused the same embryonic defects as did Alk4-i, and so did the overexpression of a dominant-negative Alk4 receptor ( Figure S2 ). The similarity of embryonic phenotypes in pharmacological and genetic assays confirms the specificity of both small molecules in zebrafish.
The examination of amputated fins treated with Alk4-i revealed normal re-epithelialization of the wound at 3 hpa: Several layers of epithelial cells covered the resection site (Figures 2A-2D ). The initial healing was associated with the deformation of the wound margin that acquired a serrate-like appearance because of the retraction of the interrays from the amputation plane ( Figures 2C and 2D) . We anticipated that the receding of the fin interrays is caused by the mechanical tension within the tissue that pulls away the tissue edges from the cut. In contrast to the soft interrays, the skeletal elements of the rays supported the tissue and prevented from retraction. Examination of control fins at 6 to 12 hpa revealed the restoration of the fin margin ( Figure 2E ). However, the stump repair did not occur in fins treated with Alk4-i ( Figure 2F ). As a result, the truncated fins developed a serrate phenotype ( Figure 2H ). Similar phenotype was observed after SB505124 treatment (data not shown).
The invaginations of the interrays correlate with the early expression domains of actbA ( Figures 1A and  1C ). This suggests the role of actbA during stump repair. What cellular defects might account for the early block of regeneration at the phase of stump repair? As shown by BrdU-cell-proliferation assay ( Figure S3 ), and consistent with previous studies [15, 16] , enhanced cell-cycle entry was not observed between 1 and 12 hpa. It has been suggested that cell migration is essential for the initial repair of the damaged tissue before blastema formation [3, 5] . We used the phosphorylated c-Jun (p-Jun) marker [17] to visualize the migrating epidermal edge at 6 and 12 hpa. Alk-i treatment diminished the p-Jun domain by approximately 75% compared to untreated cut fins ( Figure S3 ). The results suggest that the Activin-dependent restoration of the deformed wound margin involves the activation of the c-Jun pathway.
To understand the complete lack of regeneration in fins treated with the Alk4-i, we assessed cellular mechanisms that normally contribute to blastema formation: the reorganization and proliferation of the ray mesenchyme at 18 to 24 hpa [3] . We found that the antibody against tenascin abundantly labeled disorganized mesenchyme proximal to the amputation plane ( Figure 3A and Figure S3H ). Tenascin is a large extracellular matrix protein that has been shown to be induced during tissue remodeling in mammalian wound healing and limb regeneration in newts [18, 19] . Inhibition of ActbA signaling resulted in a 2-fold reduction of the tenascin expression domain in the mesenchyme when compared with control fins ( Figures 3A and 3B ). These data suggest a mesenchymal remodeling defect in fins with blocked ActbA signaling.
To address the mitogenic role of ActbA, a BrdU-labeling assay was performed. Cell proliferation, which is normally enhanced in disorganized mesenchyme at 24 hpa [16] , was reduced by approximately 75% after Alk4-i treatment as compared to control (Figures 3A and 3B, Figure S4E ). Epidermal proliferation, on the other hand, was enhanced by the Alk4-i incubation. We concluded that the mitogenic role of ActbA signaling is tissue dependent: it has a stimulating effect on mesenchyme that gives rise to the blastema but not on the , and 24 hpa (n = 4) relative to control fins at 0 hpa (n = 3), which as a calibrator sample were normalized to 1.00. Error bars represent the standar error of the mean (SEM). p < 0.001 indicates a significant difference from the control. n refers to the number of biological samples; each sample was prepared from 15-20 fins. (A, C, E, and G) Wild-type fins at different stages of regeneration. Each panel shows a longitudinal section (left) and a fragment of the whole-mount fin (right). At 6 hpa, actbA is detected in scattered mesenchymal cells along the wound epidermis of the interrays (A). The ray contains dermal bones; the interray spans soft tissue between rays. At 12 hpa, the expression expands in the mesenchyme of the interray pockets at the cut edge (C). At 24 hpa, actbA is additionally induced in the mesenchyme underlying the wound epidermis of the rays, where the blastema is formed (arrows) (E). At 72 hpa, the expression is strongly detected in the blastema (arrows) (G). (D, F, and H) actbA expression is independent of FGF20a signaling. dob homozygous mutant fins were incubated at a restrictive temperature of 33 C. actbA mRNA is expressed in the interray pockets of dob mutant fins at 6 hpa (D), 24 hpa (F), and 72 hpa (H). No or little activin A expression is detected in the ray mesenchyme (arrows) because the blastema fails to form in dob mutants (n = 6).
epidermis. These data suggest that the lack of the regenerative outgrowth in fins with blocked ActbA signaling is caused by impaired mesenchymal disorganization and proliferation.
To determine the effect of Alk4-i on molecular specification of the blastema, we performed in situ hybridization with a msxB probe. At 48 hpa, msxB marks a mass of blastema cells distal to the amputation plane [7] (Figure 3C ). In the amputated fins treated with Alk4-i, msxB was induced only in a single row of mesenchymal cells just beneath the wound epidermis ( Figure 3D ). No expression of msxB was apparent at 4 days postamputation (dpa) or later (data not shown). Thus, rudimentary blastema cells are specified in fins with blocked ActbA signaling, even though they fail to expand distally from the amputation plane.
Activin Signaling Is Essential to Maintain Blastema Progenitor Cells
To determine the requirement of ActbA signaling for the function of the normally established blastema, we performed a drug-shift experiment. Fins were first allowed to form an outgrowth for 3 days in normal conditions, and then they were exposed to Alk4-i for 6, 12, or 24 hr. The control and experimental fish were kept in the presence of BrdU for the last 6 hr of the experiment, and cell proliferation was assessed. In all control samples, BrdU labeled most of the cells within the blastema located in the distal part of the outgrowth ( Figure 3E and data not shown). Cell proliferation was not altered by 6 hr of Alk4-i incubation; however, after 12 hr of drug exposure, blastemal proliferation was approximately 50% reduced, and further reduction was observed after 24 hr of drug shift ( Figures 3E and 3F, Figures S4A, S4B , and S4F). The expression of msxB was diminished after 24 hr of drug incubation ( Figure 3G and 3H ). This rapid decrease of BrdU incorporation suggests that the progenitor cells of the regenerate either underwent apoptosis or exited the cell cycle. The TUNEL assay excluded the first possibility because it did not reveal increase of cell death in mesenchyme of the Alk4-i-treated fins ( Figures S4C and S4D and data not shown). We concluded that the ActbA function is required to maintain the proliferative potential of the blastema.
To further test the role of ActbA signaling during the outgrowth phase, we used a knockdown morpholino (MO) technology [20] . Recently, this approach was demonstrated in regenerating fins: MO was delivered into the soft outgrowth tissue by microinjection, and in vivo electroporation followed [21] . In this study, fluoresceintagged alk4, actbA, and control MOs were injected into either the ventral or dorsal half of fin regenerates at 3 dpa, and electroporation followed. The remaining noninjected half of the regenerate served as control tissue (Figure 4 ). The effect of the MOs was assessed at 2 days after injection (5 dpa) by the comparison of the outgrowth size of the experimental and control fin halves. Although the control MOs displayed normal outgrowth, the actbA-and alk4-specific MOs resulted in approximately 50% and 80% reduction of the regenerate, respectively (Figure 4 ). Microscopic analysis of fin sections at 2 days after alk4-MO delivery revealed a relatively large number of mesenchymal and epidermal cells in the distal outgrowth that retained fluorescein-tagged MOs ( Figure 4H ). We concluded that MO-mediated knockdown of alk4 and actbA during the fin-outgrowth phase impairs normally initiated regeneration.
We demonstrated that actbA is transcriptionally induced during wound healing. Wound re-epithelialization is accompanied by the retraction of the soft interray tissue with respect to the rigid rays leading to the formation of edge indentations ( Figures S5A and S5B) . The fin is able to realign the retracted wound margin within a short time of 6 to 12 hpa ( Figure S5C ). We identified that this early regenerative event requires Activin signaling because its block leads to the serrate phenotype. The saw-toothed phenotype of the amputated edge has also been observed after the blocking of fibroblast growth factor (FGF) signaling with a small-molecularweight inhibitor [22] . Further studies will be needed to address a possible relation between both phenotypes. The early actbA domain is distinct in three ways from the blastema. First, the interray actbA expression domain is not altered in FGF20a mutant dob, which lacks the blastema [8] . Second, this actbA domain does not display enhanced proliferation, which is one of the most conspicuous markers for the developing blastema. Third, the classical blastemal markers such as msxB and msxC are not expressed in the interray pockets during wound healing [7, 16] . Thus, actbA expression demarcates a previously uncharacterized mesenchymal zone that might be involved in stump repair.
The creation of progenitor blastema cells is the key event during epimorphic limb regeneration [3] . We demonstrated that actbA is expressed in the blastema ( Figure S5D ). ActbA signaling is required for the subsequent growth and maintenance of the blastema. The process of cell proliferation during fin regeneration has been shown to be controlled by FGF signaling [8, 23] . Although FGF signaling impacts the proliferation of both epidermal and mesenchymal cells, the inhibition of ActbA blocks only blastemal proliferation. Thus, ActbA represents a specific blastemal mitogenic factor during zebrafish fin regeneration.
Experimental Procedures Animal Procedures
The following zebrafish strains were used in this study: wild-type EKKWill (Waterlife Resources [Gibsonton, FL]), a wild-type AB strain (Oregon) and a devoid of blastema (dob) temperature-sensitive mutant [8] . Fish 6-24 months of age were anaesthetized in 0.1% tricane, and caudal-fin amputations were performed with razor blades. Animals were allowed to regenerate for various times at 28. 5 C, except for dob, which was at a restrictive temperature of 33 C. Alk4/5/7 inhibitors SB431542 (Tocris) and SB505124 (Sigma-Aldrich) were dissolved in dimethyl sulfoxide (DMSO) at 10 mM stock concentration and added to fish water at a final concentration of 10 mM and 2 mM, respectively. The control animals were in water with 0.1% DMSO. Up to eight fish were treated in 1 l of water at 28. 5 C that was changed daily. For proliferation assays, BrdU (Sigma-Aldrich) was dissolved in fish water at a concentration of 50 mg/ml, and the incubation time was 6 hr. Fish survived and demonstrated no unusual behavior while in the presence of SB431542, SB505124, or BrdU solution. MO injection into the fin regenerate and electroporation were performed as previously described [21] with minor modifications. MOs were injected into one half (either dorsal or ventral) of the regenerate at 3 dpa. The other noninjected half of the fin was considered as the internal control to monitor normal growth. After injection, the entire fin was electroporated with a 5-mm-diameter tweezer electrode and Electro Square Porator ECM 830 (BTX, Harvard Apparatus) applying the following parameters: five pulses of 15V and of 50 ms duration with a 30 s pause between pulses. After the procedure, fins were photographed in bright field and in fluorescence with a GFP2 filter (Leica MZFLIII microscope with an AxioCam MRc Zeiss camera). The same fins were photographed again 2 days after morpholino delivery.
Morpholino Knockdown
For the measurement of regenerate length, the distance from the amputation plane of five lateral rays to the tip of the outgrowth was determined with Abode Photoshop CS2 software. The values obtained for the symmetric rays from the experimental and control sides (located at the same position with respect to the most lateral ray) were used to calculate the percent length of the outgrowth applying the formula: (Exp 5 days 2 Exp 3 days )/(Cont 5 days 2 Cont 3 days ) 3 100, where Exp is the length of the outgrowth of the MO-treated regenerate and Cont is the length of the corresponding outgrowth of the noninjected control side.
In Situ Hybridization
To generate antisense and control sense RNA probes, portions of the coding sequences of genes were cloned by the PCR amplification of zebrafish embryonic cDNA. The forward and reverse primers were synthesized with an addition of the promoter for T7 or T3 RNA polymerase, respectively. The following forward (F) and reverse (R) primers were used: for actbA, F: . Dig-labeled RNA antisense and sense probes were synthesized from PCR products with the Dig labeling system (Roche). In situ hybridization of zebrafish fins was performed as described [22] with proteinase K (20 mg/ml, Sigma-Aldrich) treatment adjusted to the stage of the regenerate: 1-2 min incubation for fins at 6 hpa and 12 hpa, 5-7 min for fins at 24 hpa, and 10-15 min for fins at 48 hpa or later time points.
Immunohistochemistry
The following primary antibodies were used: mouse anti-human keratin, pan antibody cocktail at 1:500 (USBiological); rabbit antichicken Tenascin at 1:500 (USBiological); rabbit anti-phospho-cJun (Ser73) at 1:200 (Cell Signaling Technology); and rat anti-BrdU at 1:200 (Abcam). The following secondary antibodies were used: donkey anti-mouse Cy3-conjugated at 1:500 (Jackson ImmunoResearch); goat anti-rabbit Cy3-conjugated at 1:500 (Jackson ImmunoResearch); goat anti-rabbit Alexa Fluor 488 at 1:500 (Molecular Probes); and goat anti-rat Alexa Fluor 488 at 1:500 (Molecular Probes). ToPro3 (Molecular Probes) was used at a concentration of 1:500 to label all nuclei.
Fins were fixed in 4% paraformaldehyde, cryosectioned, and immunostained as previously described [16] . The images were taken with confocal microscopy (Nikon). To quantify BrdU-and phospho-c-Jun-positive nuclei, a number of immunostained cells were normalized to ToPro3-stained nuclei in each section. The inhibitorinduced change in the number of immunostained cells was calculated as a percentage of control values. , and alk4 (E and F) fluorescein-tagged MOs and then electroporated. Bright-field and fluorescent images show fins at 3 dpa shortly after MO delivery to the regenerate (A, C, and E). Fluorescent MOs (green) are seen only in the injected half of the fin. The remaining noninjected half of the fin served an internal control for the growth rate. Corresponding images of the fins 2 days after MO delivery (5 dpa) are shown (B, D, and F). The control MO does not affect the size of the outgrowth relative to the noninjected side of the fin (B). The actbA and alk4 MOs impair the growth of the injected fin relative to the noninjected side, leading to the asymmetric shape of the regenerate (D and F). (G) Graph comparing the length of regenerates that regrew within 2 days after MO delivery in relation to the nontreated fin regenerate. It depicts the percent length of the outgrowth of the experimental side in relation to the control side (ten fins were analyzed, five of which were either ventrally or dorsally injected). Error bars represent the SEM. The asterisks denote the significant difference, p < 0.005. (H) Longitudinal section of the fin at 2 days after the alk4 fluorescent MOs delivery (5 dpa). Fluorescent (green) cells are identified in the epidermis and within the mesenchymal tissue distal to the amputation plane, indicating the efficiency of MO incorporation. DAPI in blue labels all nuclei.
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